GENERATION HD2
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen in Individuals With Prodromal and Early Manifest Huntington's Disease.
Approved information available in German only: follow this LINK
Status: recruiting active.
See also the information on clinicaltrials.gov